All the news Showing 10 of 189 articles from: Disease course and symptomsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources The incidence of diabetes, stroke and kidney disease falls after hepatitis C cure Keith Alcorn / 12 November 2018 The incidence of some of the most serious extrahepatic health problems caused by hepatitis C declines sharply after the infection is cured by antiviral treatment, a review of people treated for hepatitis ... US FDA approves pembrolizumab immunotherapy for liver cancer Liz Highleyman / 12 November 2018 The US Food and Drug Administration last week granted accelerated approval for pembrolizumab (Keytruda), an immunotherapy drug known as a checkpoint inhibitor, for people with hepatocellular carcinoma (HCC). Over years or decades chronic hepatitis B ... How Does Curing Hepatitis C Affect Long-Term Liver Cancer Risk? Hep / 29 October 2018 What support do people with liver cirrhosis and their families need? Keith Alcorn / 09 October 2018 People with liver cirrhosis and their families need more information about their condition and prognosis and greater access to palliative care, a systematic review of studies on the needs of people with cirrhosis ... Deaths from end-stage liver disease due to HCV fall in United Kingdom Keith Alcorn / 22 August 2018 Deaths from end-stage liver disease and liver cancer caused by hepatitis C in the United Kingdom fell by 11% in 2017, provisional figures from Public Health England released on 28 July show. Most ... DAA HCV Therapy Possible in Successfully Treated Hepatocellular Carcinoma Infectious Disease Advisor / 09 July 2018 Immune system does not recover despite cured hepatitis C infection Karolinska Institutet / 13 June 2018 SVR after HCV therapy reduces extrahepatic mortality, manifestations Healio Hepatology / 01 May 2018 Local therapy with sorafenib does not improve liver cancer survival Liz Highleyman / 23 April 2018 Combining sorafenib (Nexavar) with internal radiation therapy or transarterial chemoembolization did not improve overall survival for people with liver cancer, but it did appear to help certain groups of patients, according to research presented ... New EASL hepatitis C recommendations emphasise simplicity Liz Highleyman / 23 April 2018 The European Association for the Study of the Liver (EASL) released its latest hepatitis C treatment recommendations at the 2018 International Liver Congress this month in Paris. The guidelines are available online in ... ← Prev12345...19Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive